| |
| |
|
| Insider
Information: |
Ostertag Eric |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
827,320 |
|
|
Indirect Shares
|
5,201,240 |
|
|
| Direct
Value |
$2,457,140 |
|
|
|
Indirect Value
|
$15,447,683 |
|
|
| Total
Shares |
6,028,560 |
|
|
| Total
Value |
$17,904,823 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Poseida Therapeutics, Inc. |
PSTX |
Director |
2023-02-01 |
827,320 |
2023-02-01 |
5,201,240 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive OfficerOfficer |
• • • |
2020-07-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
364,056 |
|
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive OfficerOfficer |
• • • |
2020-07-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,952,122 |
|
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2020-07-14 |
4 |
A |
$0.00 |
$0 |
I/I |
606,541 |
350,696 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-01-21 |
4 |
AS |
$10.00 |
$44,620 |
I/I |
(4,462) |
346,234 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-02-10 |
4 |
OE |
$1.29 |
$87,119 |
D/D |
67,534 |
431,590 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-02-10 |
4 |
AS |
$10.00 |
$123,890 |
I/I |
(12,389) |
333,845 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-02-16 |
4 |
AS |
$10.00 |
$1,332,036 |
I/I |
(133,149) |
200,696 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-02-23 |
4 |
OE |
$1.17 |
$130,666 |
D/D |
111,395 |
542,985 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-03-01 |
4 |
AS |
$11.66 |
$676,046 |
I/I |
(57,940) |
3,617,401 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-03-02 |
4 |
AS |
$11.54 |
$658,415 |
I/I |
(57,060) |
3,590,111 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-05-03 |
4 |
AS |
$9.01 |
$165,117 |
I/I |
(18,326) |
3,526,346 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-05-04 |
4 |
AS |
$8.44 |
$303,722 |
I/I |
(35,986) |
3,509,135 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-06-01 |
4 |
AS |
$8.61 |
$354,680 |
I/I |
(41,194) |
3,489,434 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-06-02 |
4 |
AS |
$8.34 |
$339,621 |
I/I |
(40,722) |
3,469,958 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-07-01 |
4 |
AS |
$9.77 |
$200,901 |
I/I |
(20,563) |
3,460,124 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-07-02 |
4 |
AS |
$8.90 |
$245,274 |
I/I |
(27,542) |
3,446,952 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-08-02 |
4 |
AS |
$8.13 |
$111,682 |
I/I |
(13,737) |
3,440,382 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-08-03 |
4 |
AS |
$7.99 |
$159,289 |
I/I |
(19,936) |
3,430,847 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-08-06 |
4 |
OE |
$9.15 |
$1,017,013 |
D/D |
111,149 |
654,134 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-09-01 |
4 |
AS |
$8.46 |
$432,721 |
I/I |
(51,149) |
3,406,384 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-09-02 |
4 |
AS |
$8.34 |
$510,925 |
I/I |
(61,262) |
3,377,085 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-09-13 |
4 |
OE |
$1.17 |
$172,729 |
D/D |
21,281 |
675,415 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-09-14 |
4 |
AS |
$8.14 |
$162,712 |
I/I |
(20,000) |
180,696 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-09-20 |
4 |
AS |
$8.00 |
$160,020 |
I/I |
(20,000) |
160,696 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Executive Officer |
• • • |
2021-10-01 |
4 |
AS |
$7.02 |
$140,604 |
I/I |
(20,029) |
3,367,506 |
0 |
% |
|
33 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
